Effects of different exercise modes on the urinary metabolic fingerprint of men with and without metabolic syndrome

Metabolites

Volumn 7, Issue 1, 2017, Pages

  Siopi, Aikaterina ^a   Deda, Olga ^a   Manou, Vasiliki ^a   Kellis, Spyros ^a   Kosmidis, Ioannis ^a   Komninou, Despina ^b   Raikos, Nikolaos ^a   Christoulas, Kosmas ^a   Theodoridis, Georgios A ^a   Mougios, Vassilis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

Author keywords

Exercise mode; Metabolic syndrome; Metabolomics; Urinary metabolites

Indexed keywords

CREATINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE; METHIONINE; NICOTINAMIDE; PYRUVIC ACID; THYMINE; TRIMETHYLAMINE; TRYPTAMINE; TRYPTOPHAN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY; EXERCISE; EXERCISE INTENSITY; HIGH INTENSITY INTERVAL TRAINING; HUMAN; INTRAPERITONEAL FAT; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METABOLIC SYNDROME X; METABOLOMICS; MIDDLE AGED; MORBIDITY; OXYGEN CONSUMPTION; PEDOMETER; RESISTANCE TRAINING; URINALYSIS;

EID: 85012966831     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo7010005     Document Type: Article

References (54)

1. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr.. et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [PubMed]
2. Braun, S.; Bitton-Worms, K.; LeRoith, D. The link between the metabolic syndrome and cancer. Int. J. Biol. Sci. 2011, 7, 1003–1015. [CrossRef] [PubMed]
3. Ford, E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005, 28, 1769–1778. [CrossRef] [PubMed]
4. O’Neill, S.; O’Driscoll, L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes. Rev. 2015, 16, 1–12. [CrossRef] [PubMed]
5. Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1428. [CrossRef]
6. Batch, B.C.; Shah, S.H.; Newgard, C.B.; Turer, C.B.; Haynes, C.; Bain, J.R.; Muehlbauer, M.; Patel, M.J.; Stevens, R.D.; Appel, L.J. et al. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism 2013, 62, 961–969. [CrossRef] [PubMed]
7. Newgard, C.B.; An, J.; Bain, J.R.; Muehlbauer, M.J.; Stevens, R.D.; Lien, L.F.; Haqq, A.M.; Shah, S.H.; Arlotto, M.; Slentz, C.A. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9, 311–326. [CrossRef] [PubMed]
8. Bogl, L.H.; Kaye, S.M.; Ramo, J.T.; Kangas, A.J.; Soininen, P.; Hakkarainen, A.; Lundbom, J.; Lundbom, N.; Ortega-Alonso, A.; Rissanen, A. et al. Abdominal obesity and circulating metabolites: A twin study approach. Metabolism 2016, 65, 111–121. [CrossRef] [PubMed]
9. Wurtz, P.; Soininen, P.; Kangas, A.J.; Ronnemaa, T.; Lehtimaki, T.; Kahonen, M.; Viikari, J.S.; Raitakari, O.T.; Ala-Korpela, M. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 2013, 36, 648–655. [CrossRef] [PubMed]
10. Cheng, S.; Rhee, E.P.; Larson, M.G.; Lewis, G.D.; McCabe, E.L.; Shen, D.; Palma, M.J.; Roberts, L.D.; Dejam, A.; Souza, A.L. et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012, 125, 2222–2231. [CrossRef] [PubMed]
11. Wang-Sattler, R.; Yu, Z.; Herder, C.; Messias, A.C.; Floegel, A.; He, Y.; Heim, K.; Campillos, M.; Holzapfel, C.; Thorand, B. et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 2012, 8, 615. [CrossRef] [PubMed]
12. Huang, C.F.; Cheng, M.L.; Fan, C.M.; Hong, C.Y.; Shiao, M.S. Nicotinuric acid: A potential marker of metabolic syndrome through a metabolomics-based approach. Diabetes Care 2013, 36, 1729–1731. [CrossRef] [PubMed]
13. Gall, W.E.; Beebe, K.; Lawton, K.A.; Adam, K.P.; Mitchell, M.W.; Nakhle, P.J.; Ryals, J.A.; Milburn, M.V.; Nannipieri, M.; Camastra, S. et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 2010, 5, e10883. [CrossRef] [PubMed]
14. Koves, T.R.; Ussher, J.R.; Noland, R.C.; Slentz, D.; Mosedale, M.; Ilkayeva, O.; Bain, J.; Stevens, R.; Dyck, J.R.; Newgard, C.B. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7, 45–56. [CrossRef] [PubMed]
15. Pietilainen, K.H.; Sysi-Aho, M.; Rissanen, A.; Seppanen-Laakso, T.; Yki-Jarvinen, H.; Kaprio, J.; Oresic, M. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects—A monozygotic twin study. PLoS ONE 2007, 2, e218. [CrossRef] [PubMed]
16. Wang, Z.; Klipfell, E.; Bennett, B.J.; Koeth, R.; Levison, B.S.; Dugar, B.; Feldstein, A.E.; Britt, E.B.; Fu, X.; Chung, Y.M. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472, 57–63. [CrossRef] [PubMed]
17. Lakka, T.A.; Laaksonen, D.E.: Physical activity in prevention and treatment of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 2007, 32, 76–88. [CrossRef] [PubMed]
18. Roberts, C.K.; Hevener, A.L.; Barnard, R.J. Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training. Compr. Physiol. 2013, 3. [CrossRef]
19. Whyte, L.J.; Gill, J.M.; Cathcart, A.J. Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men. Metabolism 2010, 59, 1421–1428. [CrossRef] [PubMed]
20. Jorge, M.L.; de Oliveira, V.N.; Resende, N.M.; Paraiso, L.F.; Calixto, A.; Diniz, A.L.; Resende, E.S.; Ropelle, E.R.; Carvalheira, J.B.; Espindola, F.S. et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 2011, 60, 1244–1252. [CrossRef] [PubMed]
21. 1H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J. Proteome Res. 2010, 9, 6405–6416. [CrossRef] [PubMed]
22. Pechlivanis, A.; Kostidis, S.; Saraslanidis, P.; Petridou, A.; Tsalis, G.; Veselkov, K.; Mikros, E.; Mougios, V.; Theodoridis, G.A. 1H NMR study on the short- and long-term impact of two training programs of sprint running on the metabolic fingerprint of human serum. J. Proteome Res. 2013, 12, 470–480. [CrossRef] [PubMed]
23. Lewis, G.D.; Farrell, L.; Wood, M.J.; Martinovic, M.; Arany, Z.; Rowe, G.C.; Souza, A.; Cheng, S.; McCabe, E.L.; Yang, E. et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2010, 2, 33ra7. [CrossRef] [PubMed]
24. Oberbach, A.; Bluher, M.; Wirth, H.; Till, H.; Kovacs, P.; Kullnick, Y.; Schlichting, N.; Tomm, J.M.; Rolle-Kampczyk, U.; Murugaiyan, J. et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J. Proteome Res. 2011, 10, 4769–4788. [CrossRef] [PubMed]
25. Kuehnbaum, N.L.; Gillen, J.B.; Gibala, M.J.; Britz-McKibbin, P. Personalized metabolomics for predicting glucose tolerance changes in sedentary women after high-intensity interval training. Sci. Rep. 2014, 4. [CrossRef] [PubMed]
26. Huffman, K.M.; Slentz, C.A.; Bateman, L.A.; Thompson, D.; Muehlbauer, M.J.; Bain, J.R.; Stevens, R.D.; Wenner, B.R.; Kraus, V.B.; Newgard, C.B. et al. Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity. Diabetes Care 2011, 34, 174–176. [CrossRef] [PubMed]
27. Huffman, K.M.; Koves, T.R.; Hubal, M.J.; Abouassi, H.; Beri, N.; Bateman, L.A.; Stevens, R.D.; Ilkayeva, O.R.; Hoffman, E.P.; Muoio, D.M. et al. Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. Diabetologia 2014, 57, 2282–2295. [CrossRef] [PubMed]
28. Campbell, C.; Grapov, D.; Fiehn, O.; Chandler, C.J.; Burnett, D.J.; Souza, E.C.; Casazza, G.A.; Gustafson, M.B.; Keim, N.L.; Newman, J.W. et al. Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin. PLoS ONE 2014, 9, e84260. [CrossRef] [PubMed]
29. Wu, J.; Gao, Y. Physiological conditions can be reflected in human urine proteome and metabolome. Expert Rev. Proteomics 2015, 12, 623–636. [CrossRef] [PubMed]
30. Yokota, T.; Kinugawa, S.; Okita, K.; Hirabayashi, K.; Suga, T.; Hattori, M.; Nakagawa, Y.; Oyama-Manabe, N.; Shirato, H.; Tsutsui, H. Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome. Hypertens. Res. 2011, 34, 1029–1034. [CrossRef] [PubMed]
31. Sheffield-Moore, M.; Dillon, E.L.; Randolph, K.M.; Casperson, S.L.; White, G.R.; Jennings, K.; Rathmacher, J.; Schuette, S.; Janghorbani, M.; Urban, R.J. et al. Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss. J. Cachexia Sarcopenia Muscle 2014, 5, 19–25. [CrossRef] [PubMed]
32. Elliott, P.; Posma, J.M.; Chan, Q.; Garcia-Perez, I.; Wijeyesekera, A.; Bictash, M.; Ebbels, T.M.; Ueshima, H.; Zhao, L.; van Horn, L. et al. Urinary metabolic signatures of human adiposity. Sci. Transl. Med. 2015, 7. [CrossRef] [PubMed]
33. Haus, J.M.; Miller, B.F.; Carroll, C.C.; Weinheimer, E.M.; Trappe, T.A. The effect of strenuous aerobic exercise on skeletal muscle myofibrillar proteolysis in humans. Scand. J. Med. Sci. Sports 2007, 17, 260–266. [PubMed]
34. Trappe, T.; Williams, R.; Carrithers, J.; Raue, U.; Esmarck, B.; Kjaer, M.; Hickner, R. Influence of age and resistance exercise on human skeletal muscle proteolysis: A microdialysis approach. J. Physiol. 2004, 554, 803–813. [CrossRef] [PubMed]
35. Muoio, D.M.; Noland, R.C.; Kovalik, J.P.; Seiler, S.E.; Davies, M.N.; DeBalsi, K.L.; Ilkayeva, O.R.; Stevens, R.D.; Kheterpal, I.; Zhang, J. et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 2012, 15, 764–777. [CrossRef] [PubMed]
36. Seiler, S.E.; Martin, O.J.; Noland, R.C.; Slentz, D.H.; DeBalsi, K.L.; Ilkayeva, O.R.; An, J.; Newgard, C.B.; Koves, T.R.; Muoio, D.M.: Obesity and lipid stress inhibit carnitine acetyltransferase activity. J. Lipid. Res. 2014, 55, 635–644. [CrossRef] [PubMed]
37. Thyfault, J.P.; Rector, R.S.; Noland, R.C. Metabolic inflexibility in skeletal muscle: A prelude to the cardiometabolic syndrome? J. Cardiometab. Syndr. 2006, 1, 184–189. [CrossRef] [PubMed]
38. Prior, S.J.; Ryan, A.S.; Stevenson, T.G.; Goldberg, A.P. Metabolic inflexibility during submaximal aerobic exercise is associated with glucose intolerance in obese older adults. Obesity (Silver Spring) 2014, 22, 451–457. [CrossRef] [PubMed]
39. Ekman, C.; Elgzyri, T.; Strom, K.; Almgren, P.; Parikh, H.; Dekker Nitert, M.; Ronn, T.; Manderson Koivula, F.; Ling, C.; Tornberg, A.B. et al. Less pronounced response to exercise in healthy relatives to type 2 diabetic subjects compared with controls. J. Appl. Physiol. 2015, 119, 953–960. [CrossRef] [PubMed]
40. Baker, J.S.; McCormick, M.C.; Robergs, R.A. Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise. J. Nutr. Metab. 2010, 2010, 905612. [CrossRef] [PubMed]
41. Peake, J.M.; Tan, S.J.; Markworth, J.F.; Broadbent, J.A.; Skinner, T.L.; Cameron-Smith, D. Metabolic and hormonal responses to isoenergetic high-intensity interval exercise and continuous moderate-intensity exercise. Am. J. Physiol. Endocrinol. Metab. 2014, 307, E539–E552. [CrossRef] [PubMed]
42. Gerber, T.; Borg, M.L.; Hayes, A.; Stathis, C.G. High-intensity intermittent cycling increases purine loss compared with workload-matched continuous moderate intensity cycling. Eur. J. Appl. Physiol. 2014, 114, 1513–1520. [CrossRef] [PubMed]
43. Yamamoto, T.; Koyama, H.; Kurajoh, M.; Shoji, T.; Tsutsumi, Z.; Moriwaki, Y. Biochemistry of uridine in plasma. Clin. Chim. Acta 2011, 412, 1712–1724. [CrossRef] [PubMed]
44. Fritzen, A.M.; Lundsgaard, A.M.; Jeppesen, J.; Christiansen, M.L.; Bienso, R.; Dyck, J.R.; Pilegaard, H.; Kiens, B. 5’-AMP activated protein kinase alpha2 controls substrate metabolism during post-exercise recovery via regulation of pyruvate dehydrogenase kinase 4. J. Physiol. 2015, 593, 4765–4780. [CrossRef] [PubMed]
45. 1H NMR Spectroscopy. J. Proteome Res. 2015, 14, 4610–4622. [CrossRef] [PubMed]
46. Daskalaki, E.; Easton, C.; Watson, D.G. The application of metabolomic profiling to the effects of physical activity. Curr. Metab. 2014, 2, 233–263. [CrossRef]
47. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.. et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit. Pathw. Cardiol. 2005, 4, 198–203. [CrossRef] [PubMed]
48. Huh, J.Y.; Siopi, A.; Mougios, V.; Park, K.H.; Mantzoros, C.S.: Irisin in response to exercise in humans with and without metabolic syndrome. J. Clin. Endocrinol. Metab. 2015, 100, E453–E457. [CrossRef] [PubMed]
49. Dohoney, P.; Chromiak, J.A.; Lemire, D.; Abadie, B.R.; Kovacs, C.: Prediction of one repetition maximum (1-RM) strength from a 4–6 RM and a 7–8 RM submaximal strength test in healthy young adult males. J. Exerc. Physiol. Online 2002, 5, 54–59.
50. Harris, J.A.; Benedict, F.G. A Biometric Study of Human Basal Metabolism. Proc. Natl. Acad. Sci. USA 1918, 4, 370–373. [CrossRef] [PubMed]
51. Lin, P.H.; Proschan, M.A.; Bray, G.A.; Fernandez, C.P.; Hoben, K.; Most-Windhauser, M.; Karanja, N.; Obarzanek, E.; Group, D.C.R. Estimation of energy requirements in a controlled feeding trial. Am. J. Clin. Nutr. 2003, 77, 639–645. [PubMed]
52. Virgiliou, C.; Sampsonidis, I.; Gika, H.G.; Raikos, N.; Theodoridis, G.A. Development and validation of a HILIC- MS/MS multi-targeted method for metabolomics applications. Electrophoresis 2015, 36, 2215–2225. [CrossRef] [PubMed]
53. Levy, J.C.; Matthews, D.R.; Hermans, M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21, 2191–2192. [CrossRef] [PubMed]
54. Helal, I.; Fick-Brosnahan, G.M.; Reed-Gitomer, B.; Schrier, R.W. Glomerular hyperfiltration: Definitions, mechanisms and clinical implications. Nat. Rev. Nephrol. 2012, 8, 293–300. [CrossRef] [PubMed]